By Marty Trieschmann
Fellowship-trained urologic oncologist Marcelo Bigarella, M.D., has joined the Division of Urology at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute, where he specializes in the diagnosis and management of urologic cancers, such as prostate, kidney, testicular, bladder, penile and adrenal cancer.
Bigarella joined UAMS after completing a fellowship in urologic oncology at the University of Wisconsin in Madison, one of only 40 fellowship programs in the U.S. accredited by the Society of Urologic Oncology. He has advanced expertise in open, laparoscopic and robotic surgery and is certified in DaVinci Intuitive Robotic Surgery.
“Dr. Bigarella’s passion for patient care along with his expertise in cutting-edge treatments for urological cancer will greatly benefit our patients at UAMS,” said Tim Langford, M.D., chief of the Department of Urology in the UAMS College of Medicine. “I am delighted to welcome Dr. Bigarella to our team, as he will be a tremendous asset in elevating all aspects of our mission.”
Bigarella also serves as an assistant professor in the Department of Urology in the UAMS College of Medicine. He is accepting new patients; please call 501- 296-1200 for an appointment.
Bigarella earned his medical degree from the University of Sao Paulo Medical School in Sao Paulo, Brazil, during which he completed a one-year research exchange at Duke University in Durham, North Carolina. He completed a general surgery residency, followed by urology and kidney transplant residencies at the University of Sao Paulo, where he had international rotations at Memorial Sloan Kettering in New York and the University of Vienna in Austria. He completed an additional one-year fellowship in robotic urologic surgery at the Albert Einstein Jewish Hospital in Sao Paulo, Brazil.
Bigarella’s research in next-generation imaging for prostate cancer won him a Best Poster Award at the 2024 American Urological Association Meeting. In 2023, he was invited to attend the Prostate Cancer Foundation meeting at the University of California in Los Angeles as a thought leader of the future. He has presented his research and given lectures in the most important urological meetings.